{"entity":{"type":"insider","cik":"0001551776","url":"/insider/0001551776","json_url":"/insider/0001551776.json","name":"Vittiglio Joseph","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":9,"first":"2013-01-28","last":"2025-02-05","span_basis":"filed_date"},"name_variants":[{"name":"Vittiglio Joseph","source":"filing","n_filings":9,"first_seen":"2013-01-28","last_seen":"2025-02-05"}],"transactions":[{"id":4514658,"accession":"0001562180-25-000951","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-25-000951","line_url":"/filing/0001562180-25-000951#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (Chief Business & Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business & Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business & Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":238.0,"shares_display":"238","price_per_share":7.3925,"price_display":"7.39","price_state":"stated","total_value":1759.415,"total_display":"1,759.42","total_whole":"1,759","shares_owned_after":4501.0,"shares_owned_after_display":"4,501","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-03","filed_date":"2025-02-05","scope":"insider"},{"id":2789432,"accession":"0001562180-24-001096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-24-001096","line_url":"/filing/0001562180-24-001096#line-1","is_derivative":false,"issuer_cik":"0001293971","issuer_name":"bluebird bio, Inc.","issuer_ticker":"BLUE","issuer_name_source":null,"issuer_url":"/issuer/0001293971","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (Chief Business & Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business & Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business & Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5217.0,"shares_display":"5,217","price_per_share":0.9025,"price_display":"0.90","price_state":"stated","total_value":4708.3425,"total_display":"4,708.34","total_whole":"4,708","shares_owned_after":44783.0,"shares_owned_after_display":"44,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-05","filed_date":"2024-02-06","scope":"insider"},{"id":6386557,"accession":"0000899243-22-034122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-034122","line_url":"/filing/0000899243-22-034122#line-1","is_derivative":false,"issuer_cik":"0001551776","issuer_name":"Finch Therapeutics Group, Inc.","issuer_ticker":"FNCH","issuer_name_source":null,"issuer_url":"/issuer/0001551776","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (Chief Business & Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Business & Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business & Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3636.0,"shares_display":"3,636","price_per_share":1.39,"price_display":"1.39","price_state":"stated","total_value":5054.04,"total_display":"5,054.04","total_whole":"5,054","shares_owned_after":31364.0,"shares_owned_after_display":"31,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-21","filed_date":"2022-10-25","scope":"insider"},{"id":8047936,"accession":"0000792977-19-000052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000792977-19-000052","line_url":"/filing/0000792977-19-000052#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1425.0,"shares_display":"1,425","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":19964.25,"total_display":"19,964.25","total_whole":"19,964","shares_owned_after":78955.0,"shares_owned_after_display":"78,955","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-07","filed_date":"2019-03-11","scope":"insider"},{"id":6348306,"accession":"0001179110-18-003697","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-18-003697","line_url":"/filing/0001179110-18-003697#line-5","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (EVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (EVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":770.0,"shares_display":"770","price_per_share":20.8,"price_display":"20.80","price_state":"stated","total_value":16016.0,"total_display":"16,016.00","total_whole":"16,016","shares_owned_after":52854.0,"shares_owned_after_display":"52,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-06","filed_date":"2018-03-06","scope":"insider"},{"id":5057295,"accession":"0001179110-17-011890","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-17-011890","line_url":"/filing/0001179110-17-011890#line-1","is_derivative":false,"issuer_cik":"0000792977","issuer_name":"AMAG PHARMACEUTICALS INC.","issuer_ticker":"AMAG","issuer_name_source":null,"issuer_url":"/issuer/0000792977","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250.0,"shares_display":"1,250","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":20937.5,"total_display":"20,937.50","total_whole":"20,938","shares_owned_after":33504.0,"shares_owned_after_display":"33,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-29","filed_date":"2017-08-30","scope":"insider"},{"id":8744037,"accession":"0001209191-15-003160","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-003160","line_url":"/filing/0001209191-15-003160#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4484.0,"shares_display":"4,484","price_per_share":0.8003,"price_display":"0.80","price_state":"stated","total_value":3588.5452,"total_display":"3,588.55","total_whole":"3,589","shares_owned_after":16437.0,"shares_owned_after_display":"16,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-07","filed_date":"2015-01-08","scope":"insider"},{"id":6780459,"accession":"0001181431-14-004411","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-004411","line_url":"/filing/0001181431-14-004411#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (SVP, General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP, General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5430.0,"shares_display":"5,430","price_per_share":1.6435,"price_display":"1.64","price_state":"stated","total_value":8924.205,"total_display":"8,924.20","total_whole":"8,924","shares_owned_after":34121.0,"shares_owned_after_display":"34,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-30","filed_date":"2014-01-30","scope":"insider"},{"id":5524201,"accession":"0001181431-13-005171","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-13-005171","line_url":"/filing/0001181431-13-005171#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":"0001551776","owner_name":"Vittiglio Joseph","owner_display_name":"Vittiglio Joseph","owner_url":"/insider/0001551776","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":384.0,"shares_display":"384","price_per_share":7.7711,"price_display":"7.77","price_state":"stated","total_value":2984.1024,"total_display":"2,984.10","total_whole":"2,984","shares_owned_after":29369.0,"shares_owned_after_display":"29,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-28","filed_date":"2013-01-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001293971","name":"bluebird bio, Inc.","url":"/issuer/0001293971","role":"Officer (Chief Business & Legal Officer)","n_filings":2,"first_seen":"2024-02-06","last_seen":"2025-02-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001733257","name":"Finch Therapeutics Group, Inc.","url":"/issuer/0001733257","role":"Officer (Chief Business & Legal Officer)","n_filings":1,"first_seen":"2022-10-25","last_seen":"2022-10-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000792977","name":"AMAG PHARMACEUTICALS INC.","url":"/issuer/0000792977","role":"Officer (EVP, General Counsel)","n_filings":3,"first_seen":"2017-08-30","last_seen":"2019-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS INC","url":"/issuer/0001325879","role":"Officer (SVP, General Counsel)","n_filings":3,"first_seen":"2013-01-28","last_seen":"2015-01-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001551776","retrieved_at":"2026-08-23T07:17:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}